share_log

Sangamo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Sangamo Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Sangamo Therapeutics | PRE 14A:并购重组委托声明
SEC announcement ·  04/03 17:21
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息